Stay updated on APG-115 + Pembrolizumab in Metastatic Melanomas Clinical Trial

Sign up to get notified when there's something new on the APG-115 + Pembrolizumab in Metastatic Melanomas Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the APG-115 + Pembrolizumab in Metastatic Melanomas Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The webpage has undergone significant updates, including the removal of detailed study descriptions and inclusion criteria for a clinical trial involving APG-115 and pembrolizumab, while adding new identifiers and collaborators.
    Difference
    33%
    Check dated 2025-04-16T12:48:16.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.1%
    Check dated 2025-04-09T05:38:46.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.2 to version 2.14.3.
    Difference
    0.1%
    Check dated 2025-04-01T22:40:31.000Z thumbnail image
  4. Check
    26 days ago
    No Change Detected
  5. Check
    47 days ago
    Change Detected
    Difference
    0.6%
    Check dated 2025-03-03T23:08:11.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    1%
    Check dated 2025-02-24T20:17:58.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    The webpage now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    2%
    Check dated 2025-02-10T09:36:20.000Z thumbnail image

Stay in the know with updates to APG-115 + Pembrolizumab in Metastatic Melanomas Clinical Trial

Enter your email address, and we'll notify you when there's something new on the APG-115 + Pembrolizumab in Metastatic Melanomas Clinical Trial page.